Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy

Hepatocellular carcinoma (HCC), one of the most common and lethal tumors worldwide, is usually not diagnosed until the disease is advanced, which results in ineffective intervention and unfavorable prognosis. Small molecule targeted drugs of HCC, such as sorafenib, provided only about 2.8 months of...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shao-Li, Wang, Yu-Ming, Wang, Quan-Yue, Feng, Guang-Gui, Wu, Fu-Qing, Yang, Liu-Ming, Zhang, Xi-He, Xin, Hong-Wu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296838/
https://www.ncbi.nlm.nih.gov/pubmed/34306031
http://dx.doi.org/10.3389/fgene.2021.691391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296838/
https://www.ncbi.nlm.nih.gov/pubmed/34306031
http://dx.doi.org/10.3389/fgene.2021.691391

Ejemplares similares